The global paper diagnostics market size is calculated at USD 17.43 billion in 2024, grew to USD 18.51 billion in 2025, and is predicted to hit around USD 31.80 billion by 2034, poised to grow at a CAGR of 6.2% between 2024 and 2034. The North America paper diagnostics market size accounted for USD 6.62 billion in 2024 and is anticipated to grow at the fastest CAGR of 6.33% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Paper Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Paper Diagnostics Market Revenue and Volume Forecast, by Kit Type, 2024-2034
8.1.1. Lateral Flow Assays
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Paper Based Microfluidics
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Dipsticks
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Paper Diagnostics Market Revenue and Volume Forecast, by Device Type, 2024-2034
9.1.1. Diagnostic Devices
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Monitoring Devices
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Paper Diagnostics Market Revenue and Volume Forecast, by End-use, 2024-2034
10.1.1. Assisted Living Healthcare Facilities
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Hospital and Clinics
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Home Healthcare
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1. Paper Diagnostics Market Revenue and Volume Forecast, by Application, 2024-2034
11.1.1. Food Quality Testing
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Environmental Monitoring
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Clinical Diagnostics
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.1.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.1.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.1.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.1.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.1.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.1.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.2.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.2.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.2.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.2.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.2.7.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.2.8.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.2.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.3.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.3.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.3.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.3.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.3.7.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.3.8.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.3.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.4.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.4.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.4.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.4.7.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.4.8.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.4.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.5.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.5.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)
12.5.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)
12.5.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1. Abbott (Alere Inc.)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Laboratories, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Diagnostics for All, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Arkray, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Acon Laboratories, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Ffei Life Science (Biognostix)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Kenosha Tapes
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Gvs S.P.A.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Micro Essential Laboratory Inc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Navigene
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample